Additionally, Kissler et al. [15] demonstrated that SLC11A1 gene silencing using RNAi approach in mice reduced the frequency of T1DM and protected against experimental autoimmune encephalomyelitis, advocating thereby for a role for SLC11A1 in autoimmunity. This evidence concerns the gene SLC11A1 and type 1 diabetes mellitus.